attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment
attachment

Analyse these KNRUHS pyqs and sort them as priority wise Most repeated Most likely to be asked in 2026 Less likely to be asked

analyse_media
analyse_media
analyse_media
analyse_media
analyse_media
Now I have all the data from all 9 images. Let me compile and analyze everything comprehensively.

KNRUHS Physiology PYQ Analysis - Blood Chapter

Priority Classification


πŸ”΄ TIER 1 β€” MOST REPEATED (High Priority, Study First)

These topics have appeared 5 or more times across exam years.

1. Erythropoiesis ⭐⭐⭐ (HIGHEST PRIORITY)

Appeared: ~10-12 times (Most repeated topic overall)
  • March-21, July-19, Dec-17, July/Aug-14, July-12, July-2000, Aug-1980, April-86, Oct-98, Nov-91
  • Asked as: Stages, factors, morphological changes, factors regulating erythropoiesis, effect of Vit B12/iron
  • Must prepare: All stages + factors (EPO, iron, B12, folate, androgens) + exam-ready diagram

2. Blood Coagulation / Clotting Mechanism ⭐⭐⭐

Appeared: ~8-10 times
  • Mar-21, Nov-13, May-07, Oct-1995, Oct-1993, April-84, Oct-1983, Aug-1980, Oct/Nov-18 (intrinsic pathway)
  • Asked as: Mechanism of coagulation, clotting factors, intrinsic pathway, cascade amplification, fibrinolytic system
  • Must prepare: Intrinsic + Extrinsic + Common pathway + anticoagulants together

3. Anticoagulants ⭐⭐⭐

Appeared: ~8-9 times
  • Dec-17, July-11, April-03, Feb-01, July-87, Nov-91, April-95, Oct-1998 (heparin/dicoumarol/sodium citrate), Aug-15 (intrinsic + anticoagulants)
  • Asked as: Name 3 anticoagulants + mode of action, heparin/dicoumarol/sodium citrate mechanism, Vitamin K antagonist

4. Mismatched / Incompatible Blood Transfusion ⭐⭐⭐

Appeared: ~6-7 times
  • July-21, Aug-18, Nov-14, Jan-10, April-94, Oct-1984, April-1983
  • Asked as: Hazards, effects, consequences, precautions to avoid

5. Platelets (Structure, Count, Functions) ⭐⭐

Appeared: ~8 times
  • Jan-12, Feb-2000 (Γ—2), Oct-1998, April-96, April-95, April-94, July-1991
  • Asked as: Functions, morphology + count, enumerate functions + explain one, structure

6. Functions of Plasma Proteins ⭐⭐

Appeared: ~7-8 times
  • July-19, March/April-05, April-03 (Γ—2), Aug-01, May-1988, Nov-1994, July-1991, April-1995
  • Asked as: Functions, isolation, concentration, albumin function, plasma proteins and their functions

7. Rh Factor ⭐⭐

Appeared: ~6-7 times
  • July-09, May-1999, Oct-1996, July-2000, April-1997, July-1991
  • Also embedded in Anticoagulants short Qs (April-03 old)
  • Asked as: Rh factor + significance, importance in blood transfusion

8. Blood Groups (ABO + Landsteiner's Laws) ⭐⭐

Appeared: ~6 times
  • July-13, Sep/Oct-07, Feb-09, Oct-04, Oct-1999, May-1988, Oct/Nov-02, Oct-1998
  • Asked as: Blood group systems, physiological basis, Landsteiner's laws, determine own blood group

9. Anaemia (Classification + Types) ⭐⭐

Appeared: ~5-6 times
  • Jan-12, Sep/Oct-07, Feb-2000, May-1999 (long Qs); Nov-20, Jan-11, July-09 (very short Qs)
  • Asked as: Anaemia, nutritional deficiency anaemias, classify anaemias, macrocytic/megaloblastic, morphological classification

🟠 TIER 2 β€” MOST LIKELY TO BE ASKED IN 2026

Based on: recently asked (2017-2021), cyclical patterns, and topics not asked in a while but fundamental.
TopicLast AskedLikelihood Reason
ErythropoiesisMarch-21Asked in every recent exam; always comes back
ErythropoietinJuly-21, July-18, July-103 consecutive July exams - due again
WBC / Leucocytes (Functions, Types)July-21 (VSQ), April-03Very short Qs trend upward post-2018
Eosinophils / Role in allergyMarch-21, Oct/Nov-18Repeated in last 2 exams
Blood coagulation (intrinsic)Oct/Nov-18, Aug-16Due as a long question again
Erythroblastosis FetalisJuly-21, July-11, Sep-06Asked as short Q in July-21
HaemophiliaJuly-21, Feb-01Returned in July-21 after long gap
Humoral immunityJuly-21, Feb-2000Long gap - returned 2021
T-lymphocytes / ImmunityAug-17, July/Aug-14Regular 3-year cycle
Anti-Coagulants (VSQ)Dec-17, Jan-10, Sep/Oct-07Steady short Q frequency
ESR (define + normal + factors)Aug-16, Aug-15, Jan-11Short Q staple
Megaloblastic AnaemiaOct/Nov-18Clinical relevance, due for repeat
Reticulo-endothelial systemAug-18, April-03Recent reappearance
Haemostasis + Bleeding disordersApril-03 + Feb-01Due for a long Q revival
Mismatched transfusionJuly-21Just appeared - may come as short Q
Plasma proteinsJuly-19Recent long Q appearance

🟒 TIER 3 β€” LESS LIKELY TO BE ASKED IN 2026

These are older questions (pre-2000, appeared only once or twice, or very niche topics):
TopicLast AskedReason Less Likely
Reticular formationNov-1994Very old, niche neurophysiology topic
Hypothalamus nuclei / integrative processesOct-1993Very old, rarely repeated
Body defense mechanisms (skin/mouth/airway)Feb-2000Vague, non-specific - rarely revisited
Haemorrhage & compensatory mechanismsFeb-2001 (old)Old format question
Blood volume + estimationOct-1997, Nov-1994Rarely asked in recent years
Fick's principleAug-2001Cardio topic, appeared only once
Indicator dilution techniqueApril-03Appeared once
Physiological leucocytosis causesMarch/April-05Appeared once
Packed cell volume in haemorrhagic shockSep-06Niche clinical application
Normal diameter of erythrocytesOct-1996, Nov-1992Very old
Normal life span of RBC + determinationOct-1996Old and narrow
Oncotic pressure of plasmaOct-1993Very old
Basophil and its functionsApril-1995Single appearance
Formation of lymph / compositionOct-1993Old, low recent frequency
Vitamin K dependent clotting factorsJuly/Aug-14Appears occasionally as VSQ
Secretory vesicles / Exocytosis / MitochondriaJan-12, Jan-11, Feb-09General physiology, not blood-specific
Erythroblastosis fetalis (as long Q)Oct-1983Only as short Q recently
Blood transfusion rules (Apr-1983)April-1983Very old long Q format
Protein functions of plasma (Apr-1985)April-1985Extremely old

πŸ“Š Quick Reference Summary Table

PriorityTopicTimes AskedFocus Area
πŸ”΄ #1Erythropoiesis10-12Γ—Stages + Factors + Regulation
πŸ”΄ #2Blood Coagulation8-10Γ—Intrinsic + Extrinsic + Cascade
πŸ”΄ #3Anticoagulants8-9Γ—Heparin, Dicoumarol, Sodium Citrate
πŸ”΄ #4Mismatched Transfusion6-7Γ—Effects + Hazards + Precautions
πŸ”΄ #5Platelets8Γ—Structure + Count + Functions
πŸ”΄ #6Plasma Proteins7-8Γ—Types + Functions + Albumin
πŸ”΄ #7Rh Factor6-7Γ—Significance + Incompatibility
πŸ”΄ #8Blood Groups / Landsteiner6Γ—ABO system + Clinical importance
πŸ”΄ #9Anaemia5-6Γ—Classification + Nutritional types
🟠 #10Erythropoietin3Γ— (all July!)EPO mechanism + renal role
🟠 #11T & B lymphocytes / Immunity4Γ—Role in immunity
🟠 #12ESR3Γ—Definition + Normal value + Factors
🟠 #13Erythroblastosis Fetalis4Γ—Cause + Prevention + Rh basis
🟠 #14Haemostasis + Haemophilia4Γ—Haemostasis process + bleeding disorders
🟠 #15Leucocytes (WBC types + functions)4Γ—Classification + Defense role
🟠 #16Jaundice / Haemolytic Jaundice3Γ—Types + Clinical distinction
🟠 #17Haemoglobin (structure/catabolism)2Γ—Formation factors + breakdown
🟠 #18Reticulo-endothelial System2Γ— (recent)Functions + Cell types
🟠 #19Fate of Hb / RBC3Γ—Post-hemolysis pathway
🟠 #20Megaloblastic Anaemia1Γ— (recent)Causes + features
🟒Reticular formation1Γ— (1994)Very old
🟒Hypothalamus nuclei1Γ— (1993)Very old
🟒Fick's principle1Γ—Cardio/not blood
🟒Blood volume estimation2Γ— (old)Old format
🟒Oncotic pressure1Γ— (1993)Very old

🎯 2026 Exam Strategy

Guaranteed to study (Tier 1 + high Tier 2):
  1. Erythropoiesis (with diagram)
  2. Blood coagulation - both intrinsic & extrinsic pathways
  3. Anticoagulants (heparin, warfarin, sodium citrate + mechanisms)
  4. Platelets - structure, count, functions
  5. Plasma proteins - types, concentrations, functions
  6. Blood groups + Rh factor
  7. Mismatched blood transfusion - hazards & effects
  8. Anaemia - classification (morphological + etiological)
  9. Erythropoietin
  10. T/B lymphocytes + immunity
Short note goldmines (Very Short Q likely in 2026):
  • ESR, Eosinophils, Erythroblastosis fetalis, Haemophilia, Anti-coagulants, Lymph, Functions of spleen, Land Steiner's law, Cross matching, WBC functions

Hazards effects and consequences of mismatched blood transfusions

A mismatched blood transfusion occurs when donor blood is ABO/Rh incompatible with the recipient, triggering an acute hemolytic transfusion reaction - the most dangerous transfusion complication. The donated RBCs are rapidly destroyed by pre-formed antibodies, activating complement, coagulation, and inflammatory cascades. Key consequences include intravascular hemolysis, renal failure, DIC, and shock.
Searching sources...
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Reading File
I now have excellent, comprehensive data from multiple authoritative textbooks. Here is the complete answer:

Hazards, Effects & Consequences of Mismatched Blood Transfusion

Definition

A mismatched (incompatible) blood transfusion occurs when donor blood is ABO or Rh incompatible with the recipient. The recipient's pre-formed antibodies (anti-A or anti-B IgM) bind to transfused RBC antigens, triggering a life-threatening Acute Hemolytic Transfusion Reaction (AHTR). Reactions can begin with as little as 10-15 mL of incompatible blood.

Mechanism (Pathophysiology)

The diagram below from Harrison's Principles of Internal Medicine (2025) illustrates the three pathways:
Mechanisms of transfusion hemolytic reactions
Step-by-step cascade:
  1. Recipient anti-A/anti-B IgM antibodies bind to donor RBC surface antigens
  2. Antigen-antibody complex activates the complement cascade (C1 β†’ C3 β†’ C5 β†’ C5b-C9)
  3. Membrane Attack Complex (MAC) forms pores in donor RBC membranes
  4. Intravascular hemolysis - massive destruction of transfused RBCs
  5. Free hemoglobin floods the plasma β†’ hemoglobinemia
  6. Complement fragments C3a and C5a activate mast cells β†’ release cytokines (IL-1, IL-6, IL-8, TNF-Ξ±)
  7. Kallikrein-kinin system activation β†’ bradykinin release β†’ hypotension
  8. RBC stroma releases erythrocytin β†’ activates intrinsic coagulation β†’ DIC
  9. Free Hb precipitates as acid hematin in distal tubules β†’ acute renal failure

Classification of Hazards

Transfusion hazards are broadly divided into:

A. Immunological Reactions

TypeOnsetMechanism
Acute Hemolytic ReactionDuring/within 24 hrsABO/Rh incompatibility β†’ intravascular hemolysis
Delayed Hemolytic Reaction3-10 days post transfusionIgG antibodies β†’ extravascular hemolysis in RES (spleen/liver)
Febrile Non-HemolyticDuring transfusionCytokines in blood products / recipient antibodies vs donor WBCs
Allergic/AnaphylacticMinutesIgE mediated; anti-IgA antibodies in IgA-deficient recipients
Transfusion-related Acute Lung Injury (TRALI)Within 6 hrsDonor anti-HLA antibodies activate recipient neutrophils in lungs

B. Non-Immunological Reactions

  • Circulatory overload (TACO)
  • Bacterial contamination / septic reaction
  • Air embolism
  • Hypocalcemia (from citrate in stored blood)
  • Hyperkalaemia
  • Hypothermia from cold blood

Effects & Consequences of Acute Hemolytic Reaction

1. Immediate Symptoms (Clinical Features)

SymptomSignificance
Fever + chills/rigorsMost common sign (complement + cytokine release)
Lumbar/flank painRenal ischemia from Hb precipitation
Chest pain + dyspneaAgglutination in pulmonary vasculature
Hypotension / shockKallikrein-kinin activation β†’ bradykinin β†’ vasodilation
Facial flushingHistamine release from mast cells
Nausea, vomitingSystemic inflammatory response
Hemoglobinuria (dark red urine)Free Hb exceeds haptoglobin binding capacity (>150 mg/dL plasma Hb)
Bleeding at IV siteEarly sign of DIC
Under general anesthesia, fever and pain are masked - the presenting signs are hemoglobinuria, unexplained hypotension, or bleeding diathesis - Miller's Anesthesia, 10e.

2. Acute Renal Failure (Most Serious Consequence)

Mechanism:
  • Free Hb saturates plasma haptoglobin (capacity ~100 mg Hb/100 mL plasma)
  • Excess free Hb reaches kidneys β†’ in acidic urine, precipitates as acid hematin in distal convoluted tubules
  • Mechanical tubular obstruction β†’ oliguria/anuria
  • Additionally, renal vasoconstriction from nitric oxide scavenging by free Hb reduces renal blood flow β†’ acute tubular necrosis (ATN)
  • Result: Acute Kidney Injury (AKI)

3. Disseminated Intravascular Coagulation (DIC)

Mechanism:
  • Lysed RBC stroma releases erythrocytin (thromboplastin-like substance)
  • Activates the intrinsic clotting pathway
  • Consumption of clotting factors I (fibrinogen), II, V, VIII, and platelets
  • Simultaneously, fibrinolysis is activated
  • Net result: paradoxical bleeding despite widespread clotting
Lab findings in DIC:
  • Prolonged PT and PTT
  • Decreased fibrinogen
  • Decreased platelet count
  • Elevated FDPs (Fibrin Degradation Products)
  • Positive D-dimer

4. Shock (Circulatory Collapse)

  • Complement activation β†’ C3a, C5a β†’ mast cell degranulation β†’ histamine + serotonin release β†’ vasodilation
  • Kallikrein-kinin activation β†’ bradykinin β†’ marked hypotension
  • Combined with haemorrhage from DIC β†’ cardiogenic + distributive shock
  • Death may result from anaphylaxis, renal failure, electrolyte imbalance, or circulatory overload

5. Jaundice (Prehepatic / Haemolytic)

  • Massive intravascular haemolysis β†’ large amounts of unconjugated bilirubin released
  • Liver temporarily overwhelmed β†’ unconjugated hyperbilirubinemia
  • Scleral icterus, jaundice appear within hours
  • Urine shows urobilinogen, urobilin, and red cell casts

6. Delayed Hemolytic Reaction (3-10 days later)

  • Occurs with minor antigen incompatibilities (Kidd, Duffy, Kell systems)
  • Recipient has low-titre IgG antibodies from prior sensitization (pregnancy/previous transfusion)
  • Complement activation stops at C3b β†’ opsonization β†’ extravascular hemolysis in the RES (spleen, liver)
  • Milder presentation: anaemia, jaundice, fever, positive DAT
  • NO hemoglobinuria (as haemolysis is extravascular)

Investigations After Suspected Mismatched Transfusion

  1. Stop the transfusion immediately
  2. Haematological: Hb, PCV, haptoglobin (decreased), LDH (elevated), peripheral smear (spherocytes)
  3. Urine: Hemoglobinuria, urobilinogen, red cell casts
  4. Serology: Direct Antiglobulin Test / Coombs test (positive), cross-match repeat
  5. Coagulation: PT, aPTT, fibrinogen, platelet count (for DIC)
  6. Serum bilirubin: Unconjugated fraction raised
  7. Bacteriological: Culture of residual donor blood (to rule out bacterial contamination)

Management (Immediate Steps)

  1. Stop transfusion immediately
  2. Maintain urine output β‰₯75-100 mL/hour (IV fluids + mannitol β†’ furosemide if needed)
  3. Alkalinize urine (IV sodium bicarbonate - prevents acid hematin precipitation)
  4. Treat hypotension with IV fluids/vasopressors
  5. Manage DIC - FFP, platelets, cryoprecipitate
  6. Send blood and urine samples to blood bank
  7. Return unused blood to blood bank for repeat crossmatch
  8. Monitor for ARDS, hepatic failure

Causes of Death in Incompatible Transfusion

According to [The Essentials of Forensic Medicine & Toxicology (2026)]:
  • Anaphylactic shock (immediate)
  • Acute renal failure (hours to days)
  • DIC with uncontrollable haemorrhage
  • Electrolyte imbalance (hyperkalaemia, hypocalcaemia)
  • Circulatory overload

Precautions to Prevent Mismatched Transfusion

  1. ABO and Rh grouping of both donor and recipient
  2. Cross-matching before every transfusion (major + minor crossmatch)
  3. Check patient identity with two identifiers before administration
  4. Verify blood bag label against lab report
  5. Watch for similarly named patients in the ward (most common clerical error)
  6. Blood must be checked by two trained personnel
  7. Use barcode scanning systems in modern settings
  8. Start transfusion slowly (first 50 mL over 15 min under observation)
  9. Screen for irregular antibodies (indirect Coombs test) in recipients with previous transfusions or pregnancies

Key exam summary: Mismatched transfusion β†’ antibody-antigen complex β†’ complement activation β†’ intravascular haemolysis β†’ free Hb β†’ renal failure (acid hematin tubular block) + DIC (erythrocytin activates coagulation) + shock (bradykinin, histamine) + jaundice (unconjugated bilirubinaemia). The triad of renal failure + DIC + shock is the hallmark of severe AHTR.

Anemia it's classifications in a flow chart form for university examination for 15 marks

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
I now have all the data needed. Let me generate a high-quality flowchart image and write a complete 15-mark answer.
Generating Image

A detailed medical flowchart for university physiology exam showing classification of anemia. The flowchart starts with "ANEMIA" at the top as the main box, then branches into three main pathways based on two classification systems. First system: "BASED ON ETIOLOGY/MECHANISM" splits into three branches: (1) "BLOOD LOSS" leading to Acute blood loss (Trauma, Surgery) and Chronic blood loss (GI lesions, Menorrhagia); (2) "INCREASED DESTRUCTION (HEMOLYTIC)" splitting into Intrinsic causes (Membrane defects: Hereditary spherocytosis, elliptocytosis; Enzyme defects: G6PD deficiency, PK deficiency; Hemoglobin defects: Sickle cell, Thalassemia) and Extrinsic causes (Immune: Autoimmune, Transfusion reactions, HDN; Non-immune: Malaria, Microangiopathy, Hypersplenism); (3) "DECREASED PRODUCTION" leading to Nutritional deficiency (Iron deficiency, B12 deficiency, Folate deficiency) and Bone marrow failure (Aplastic anemia, Myelodysplasia, Leukemia) and EPO deficiency (Chronic renal disease, Anemia of chronic disease). Second system: "BASED ON MORPHOLOGY (MCV/RBC size)" splits into three: (1) MICROCYTIC HYPOCHROMIC (MCV less than 80 fL) - Iron deficiency, Thalassemia, Sideroblastic, Anemia of chronic disease; (2) NORMOCYTIC NORMOCHROMIC (MCV 80-100 fL) - Acute blood loss, Hemolytic anemia, Aplastic anemia, Renal disease; (3) MACROCYTIC (MCV greater than 100 fL) - Megaloblastic: B12 deficiency, Folate deficiency; Non-megaloblastic: Liver disease, Alcoholism, Hypothyroidism. Use clean medical textbook style, white background, blue and dark navy color scheme for boxes, clear arrows connecting all nodes, professional font, well-organized layout suitable for MBBS university exam answer.

Classification of Anemia Flowchart

Anemia - Definition, Classification & Features (15 Marks)


Definition

Anemia is defined as a reduction in the hemoglobin concentration, hematocrit (PCV), or RBC count below the normal range for age and sex of the individual, resulting in reduced oxygen-carrying capacity of blood.
WHO Criteria (Hb below normal):
GroupHb Threshold
Adult males< 13 g/dL
Adult females< 12 g/dL
Pregnant women< 11 g/dL
Children (6-14 yrs)< 12 g/dL

Classification of Anemia

Anemia is classified by two major systems used in clinical and university examinations:

SYSTEM 1 - ETIOLOGICAL / PATHOPHYSIOLOGICAL Classification

                        β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
                        β”‚        ANEMIA        β”‚
                        β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
              β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
              β–Ό                  β–Ό                   β–Ό
    β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”   β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
    β”‚  BLOOD LOSS  β”‚   β”‚ INCREASED RBC    β”‚  β”‚ DECREASED RBC    β”‚
    β”‚              β”‚   β”‚ DESTRUCTION      β”‚  β”‚ PRODUCTION       β”‚
    β”‚  (Hemorrhagicβ”‚   β”‚ (Hemolytic       β”‚  β”‚ (Hypoprolifera-  β”‚
    β”‚   Anemia)    β”‚   β”‚  Anemia)         β”‚  β”‚  tive Anemia)    β”‚
    β””β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”˜   β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”˜
           β”‚                    β”‚                        β”‚
    β”Œβ”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”     β”Œβ”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”       β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”
    β”‚   ACUTE     β”‚     β”‚  INTRINSIC   β”‚       β”‚  EXTRINSIC      β”‚
    β”‚  Blood Loss β”‚     β”‚  (within RBC)β”‚       β”‚  (outside RBC)  β”‚
    β”‚  - Trauma   β”‚     β””β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”˜       β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”˜
    β”‚  - Surgery  β”‚             β”‚                        β”‚
    β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜     β”Œβ”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”    β”Œβ”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
    β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”    β–Ό       β–Ό           β–Ό    β–Ό       β–Ό           β–Ό
    β”‚  CHRONIC     β”‚  Mem-   Enzyme     Hb    Immune  Non-immune   
    β”‚  Blood Loss  β”‚  brane  defects    defects
    β”‚  - GI bleed  β”‚  defects          
    β”‚  - Menorrhagiaβ”‚
    β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

A. Blood Loss Anemia

1. Acute Hemorrhagic Anemia
  • Trauma, surgery, ruptured aneurysm
  • Normocytic normochromic initially
  • Reticulocytes increase after 3-5 days
2. Chronic Hemorrhagic Anemia
  • GI tract lesions (ulcer, carcinoma)
  • Gynecological: menorrhagia, fibroids
  • Eventually leads to iron deficiency β†’ microcytic hypochromic

B. Hemolytic Anemia (Increased RBC Destruction)

INTRINSIC (Defect within the RBC itself)
Sub-typeDisorders
Membrane defectsHereditary spherocytosis, Hereditary elliptocytosis
Enzyme defectsG6PD deficiency (Hexose monophosphate shunt), Pyruvate kinase deficiency (glycolytic)
Hemoglobin defectsSickle cell anemia, Thalassemia syndromes, Unstable hemoglobins
Acquired geneticParoxysmal Nocturnal Hemoglobinuria (PNH)
EXTRINSIC (Forces outside the RBC cause destruction)
Sub-typeExamples
Immune-mediatedAutoimmune hemolytic anemia, HDN (Rh disease), Transfusion reactions, Drug-induced
MicroangiopathicHUS, DIC, TTP (mechanical shearing)
InfectionsMalaria, Babesiosis, Clostridium
HypersplenismSplenomegaly β†’ increased RBC sequestration

C. Decreased Production (Hypoproliferative / Dyserythropoietic)

CauseDisorders
Nutritional deficiencyIron deficiency, B12 deficiency, Folate deficiency, Copper, Vitamin C
Bone marrow failureAplastic anemia, Pure red cell aplasia
Marrow replacementLeukemia, lymphoma, metastatic carcinoma, myelofibrosis
Stem cell defectsMyelodysplastic syndrome (MDS), Fanconi anemia
EPO deficiencyChronic renal disease, Anemia of chronic inflammation
Endocrine disordersHypothyroidism, hypopituitarism, Addison's disease

SYSTEM 2 - MORPHOLOGICAL Classification (Based on RBC Size - MCV)

This is the most clinically used and exam-favorite classification:
                        β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
                        β”‚        ANEMIA         β”‚
                        β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
         β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
         β–Ό                        β–Ό                        β–Ό
β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”   β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”   β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚    MICROCYTIC     β”‚   β”‚    NORMOCYTIC    β”‚   β”‚    MACROCYTIC    β”‚
β”‚    HYPOCHROMIC   β”‚   β”‚   NORMOCHROMIC   β”‚   β”‚                  β”‚
β”‚  MCV < 80 fL     β”‚   β”‚  MCV 80-100 fL   β”‚   β”‚  MCV > 100 fL    β”‚
β”‚  MCH < 27 pg     β”‚   β”‚  MCH 27-33 pg    β”‚   β”‚                  β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜   β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜   β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
         β”‚                       β”‚                      β”‚
  β”Œβ”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”       β”Œβ”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”     β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”
  β”‚ TAILS        β”‚       β”‚               β”‚     β”‚  MEGALOBLASTIC  β”‚
  β”‚ Iron def.    β”‚   Acute blood loss     β”‚  B12 deficiency      β”‚
  β”‚ Thalassemia  β”‚   Hemolytic anemia     β”‚  Folate deficiency   β”‚
  β”‚ Sideroblasticβ”‚   Aplastic anemia      β”‚  MDS                 β”‚
  β”‚ Anemia of    β”‚   Renal disease        β”‚  Chemotherapy        β”‚
  β”‚ chronic dis. β”‚   Hypothyroidism       β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜   Mixed deficiency     β”‚  NON-MEGALOBLASTIC  β”‚
                     β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜    β”‚  Liver disease       β”‚
                                          β”‚  Alcoholism          β”‚
                                          β”‚  Hypothyroidism      β”‚
                                          β”‚  Reticulocytosis     β”‚
                                          β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

SYSTEM 3 - Based on Bone Marrow Response (Reticulocyte Count)

TypeReticulocyte CountInterpretationExamples
Hyperregenerative> 2% (elevated)Bone marrow respondingHemolytic anemias, Acute blood loss
Hyporegenerative< 1% (low/normal)Bone marrow failingIron deficiency, Aplastic anemia, B12 deficiency, Renal anemia

Quick Comparison Table - Key Anemias

TypeMCVMCHReticulocytesKey Lab Finding
Iron deficiency↓↓↓↓ Serum ferritin, ↑ TIBC
B12 deficiency↑Normal↓Hypersegmented neutrophils, ↓ serum B12
Folate deficiency↑Normal↓↓ RBC folate
Thalassemia↓↓↑Hb electrophoresis abnormal
HemolyticNormalNormal↑↑↑ LDH, ↓ haptoglobin, +ve Coombs
AplasticNormalNormal↓↓Pancytopenia, empty marrow
Sickle cellNormalNormal↑HbS on electrophoresis
Anemia of chronic diseaseNormal/↓Normal/↓↓↓ TIBC, ↑ ferritin (trapped iron)

Clinical Features of Anemia (General)

Symptoms:
  • Fatigue, weakness, exertional dyspnea
  • Palpitations, headache, dizziness
  • Tinnitus, fainting
  • Reduced exercise tolerance
Signs:
  • Pallor (conjunctival, palmar, sublingual)
  • Tachycardia, wide pulse pressure
  • Systolic flow murmur (hyperdynamic circulation)
  • Ankle edema in severe cases
  • Specific signs: koilonychia (iron def.), glossitis (B12), jaundice (hemolytic)

Summary Flowchart (Exam-Ready)

ANEMIA
β”‚
β”œβ”€β”€ BY ETIOLOGY
β”‚   β”œβ”€β”€ Blood Loss β†’ Acute / Chronic
β”‚   β”œβ”€β”€ Hemolytic β†’ Intrinsic (membrane, enzyme, Hb defects)
β”‚   β”‚              β†’ Extrinsic (immune, microangiopathic, infection)
β”‚   └── Decreased Production β†’ Nutritional / Marrow failure / EPO deficiency
β”‚
β”œβ”€β”€ BY MORPHOLOGY (MCV)
β”‚   β”œβ”€β”€ Microcytic (<80 fL) β†’ Fe def., Thalassemia, Sideroblastic, ACD
β”‚   β”œβ”€β”€ Normocytic (80-100) β†’ Blood loss, Hemolytic, Aplastic, Renal
β”‚   └── Macrocytic (>100)  β†’ Megaloblastic (B12, Folate) / Non-megaloblastic (Liver, Alcohol)
β”‚
└── BY BONE MARROW RESPONSE
    β”œβ”€β”€ Hyperregenerative (Retics ↑) β†’ Hemolysis, Blood loss
    └── Hyporegenerative (Retics ↓) β†’ Iron def., Aplastic, B12 def.

Sources: - Harrison's Principles of Internal Medicine 22E, p. 492-495 | Robbins & Cotran Pathologic Basis of Disease, Table 14.1 | Goldman-Cecil Medicine, Chapter 144
This is a shared conversation. Sign in to Orris to start your own chat.